Asia-Pacific Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033

Asia-Pacific Targeted Sequencing Market: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Country - Analysis and Forecast, 2024-2033

Introduction to Asia-Pacific Targeted Sequencing Market

The Asia-Pacific targeted sequencing market was valued at $574.2 million in 2023 and is expected to reach $2,175.5 million by 2033, growing at a CAGR of 14.35% between 2024 and 2033. The APAC targeted sequencing market is fiercely competitive, with both established players and emerging companies vying for market share. It will be crucial to keep an eye on the market's dynamic and quickly changing landscape in the upcoming years as a result of its anticipated growth and transformation, which present both opportunities and challenges.

Market Introduction

The growing demand for affordable, high-accuracy sequencing technologies, the growing use of precision medicine, and genomics advancements are all contributing to the notable growth of the APAC targeted sequencing market. Because it provides a cost-effective and efficient substitute for whole genome sequencing, targeted sequencing—which concentrates on particular genes or regions of interest—is becoming more and more popular. Thanks to strong government funding, growing research initiatives, and the expanding biotechnology sector, nations like China, Japan, South Korea, and India are dominating the market.

The use of targeted sequencing for clinical diagnostics and individualized treatment regimens has increased due to the rise in chronic diseases, such as cancer and genetic disorders. The market is growing as a result of technological developments in next-generation sequencing (NGS) platforms and growing partnerships between academic institutions and business entities. Additionally, the APAC region’s large population, coupled with growing awareness about genomics-based healthcare, creates significant opportunities for market players.

Furthermore, targeted sequencing is particularly appealing for clinical and research applications due to its cost-effectiveness, which allows for deeper understanding of genetic variations while simplifying data analysis. The APAC targeted sequencing market is expected to grow significantly as genomics research investments rise, contributing to the advancement of precision medicine and genomic research in the region.

Market Segmentation

Segmentation 1: by Application

Cancer
Reproductive Health
Hereditary Diseases
Neurological Disorders
Infectious Diseases
Cardiovascular Diseases
Rare Diseases
Other Applications

Segmentation 2: by End User

Diagnostic and Clinical Laboratories
Academic and Research Institutions
Pharmaceutical and Biotech Companies
Other End Users

Segmentation 3: by Product Type

Instruments
Services
Kits/Panels and Assays
Others

Segmentation 4: by Target Enrichment Method

Hybridization Capture
Amplicon Sequencing
Other Target Enrichment Methods

Segmentation 5: by Target Capture

Targeted DNA Sequencing
Targeted RNA Sequencing
Other Types of Target Capture

Segmentation 6: by Country

China
Japan
South Korea
India
Australia
Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific targeted sequencing market (by application) has been segmented into detailed segments of the application of targeted sequencing based on applications, including cancer, reproductive health, hereditary diseases, neurological disorders, infectious diseases, cardiovascular diseases, rare diseases, and other applications.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enable prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Asia-Pacific targeted sequencing market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific targeted sequencing market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations are expected to aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some of the prominent companies in this market are:

BGI Group
Daicel Corporation
Takara Bio Inc.

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 1-5 business days to complete the report upon order confirmation.